Chinook Therapeutics
Vancouver
About Chinook Therapeutics
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science. The company focuses on developing precision medicines for kidney diseases. Its services offers utilization of novel translational platforms and patient stratification tools, and emergence of accelerated regulatory pathways based on surrogate endpoints.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $276.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (May 2022)
- Ticker: nasdaq:KDNY
- Website: chinooktx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/chinook-therapeutics-110721 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.